Thus, our study established the CDK4/6-USP51-ZEB1 axis as an important regulatory mechanism of breast cancer metastasis and provided a rationale for future therapeutic interventions in the treatment of advanced breast cancer (Fig. 6k). Here, CDK4 is linked to breast carcinoma.